375368-92-6Relevant articles and documents
Boron-Templated Dimerization of Allylic Alcohols to Form Protected 1,3-Diols via Acid Catalysis
Nazari, S. Hadi,Forson, Kelton G.,Martinez, Erin E.,Hansen, Nicholas J.,Gassaway, Kyle J.,Lyons, Nathan M.,Kenney, Karissa C.,Valdivia-Berroeta, Gabriel A.,Smith, Stacey J.,Michaelis, David J.
supporting information, p. 9589 - 9593 (2019/12/02)
We report an unprecedented boron-templated dimerization of allylic alcohols that generates a 1,3-diol product with two stereogenic centers in high yield and diastereoselectivity. This acid-catalyzed reaction is achieved via in situ formation of a boronic ester intermediate that facilitates selective cyclization and formation of a cyclic boronic ester product. High yields are observed with a variety of allylic alcohols, and mechanistic studies confirm the role of boron as a template for the reaction.
HETEROCYCLE AND CARBOCYCLE DERIVATIVES HAVING TRKA INHIBITORY ACTIVITY
-
Paragraph 1391-1393, (2017/09/08)
The present invention relates to a compound represented by Formula (I): wherein -L- is —C(═X)—, or the like, —Z— is —NR5—, or the like, —ZA— is —NR5A—, or the like, —W— is —C(R8R9)n-, —WA— is —C(R3R4)m-, B is substituted or unsubstituted aromatic carbocyclyl, or the like, Y is a bond, or the like, the ring C is a substituted or unsubstituted aromatic heterocycle, or the like, R2 is a hydrogen atom, or the like, or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising thereof.
P2X4 RECEPTOR MODULATING COMPOUNDS
-
Paragraph 00250, (2015/06/25)
Provided herein are P2X4 receptor modulating compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, including but not limited to, chronic pain, neuropathy, inflammatory diseases and central nervous system disorders.
